23
Views
9
CrossRef citations to date
0
Altmetric
Review

Thrombolytic and newer mechanical device treatment for acute ischemic stroke

Pages 1099-1105 | Published online: 10 Jan 2014
 

Abstract

For 8 years, only intravenous tissue plasminogen activator was approved by the US FDA for acute stroke treatment. The US FDA has now cleared the Merci® Retriever (Concentric Medical, Inc.), a corkscrew-like device attached to a catheter, for the removal of clots causing ischemic strokes. Since the clearance was based on nonrandomized treatment trials, practitioners must scrutinize available data describing effects of the device on recanalization of the vessel, outcomes and important adverse events, such as symptomatic intracranial hemorrhage. This article reviews the study findings that are likely to contribute to current treatment decisions.

Notes

aPTT: Activated partial thromboplastin time; AVM: Arteriovenous malformation; CT: Computed tomography; DBP: Diastolic blood pressure; GI: Gastrointestinal;

GU: Genito-urinary; INR: International normalized ratio; i.v.: Intravenous; NIH: National Institutes of Health; SBP: Systolic blood pressure.

Modified from Citation[23].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 651.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.